We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$42.6M
Cap. Flow
+$21.7M
Cap. Flow %
6.13%
Top 10 Hldgs %
34.16%
Holding
110
New
22
Increased
38
Reduced
31
Closed
18

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$9.24M
2
TMO icon
Thermo Fisher Scientific
TMO
+$9.06M
3
NSTG
NanoString Technologies, Inc.
NSTG
+$7.44M
4
XRAY icon
Dentsply Sirona
XRAY
+$6.15M
5
IRTC icon
iRhythm Holdings
IRTC
+$6.03M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$8.25M
2
VWR
VWR Corporation
VWR
+$7.23M
3
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$5.2M
4
WMGI
Wright Medical Group Inc
WMGI
+$4.63M
5
HOLX
Hologic
HOLX
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 88.14%
2 Financials 2.42%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
1
Thermo Fisher Scientific
TMO
$213B
$16.2M 4.57%
92,608
+53,922
+139% +$9.06M
UHS icon
2
Universal Health Services
UHS
$10.2B
$13.5M 3.81%
110,400
+15,300
+16% +$1.82M
OXFD
3
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$12.6M 3.57%
750,534
+179,563
+31% +$2.68M
ABT icon
4
Abbott
ABT
$183B
$12.2M 3.45%
250,783
-58,957
-19% -$2.67M
DVA icon
5
DaVita
DVA
$15.4B
$12M 3.4%
185,497
+27,018
+17% +$1.79M
MCK icon
6
McKesson
MCK
$100B
$12M 3.4%
73,003
+60,948
+506% +$9.24M
BCR
7
DELISTED
CR Bard Inc.
BCR
$11.6M 3.29%
36,761
+19,666
+115% +$5.84M
BDX icon
8
Becton Dickinson
BDX
$45.6B
$11M 3.11%
57,709
-14,247
-20% -$2.6M
UNH icon
9
UnitedHealth
UNH
$376B
$10.5M 2.96%
56,484
-3,772
-6% -$661K
JAZZ icon
10
Jazz Pharmaceuticals
JAZZ
$15.9B
$9.27M 2.62%
59,600
-1,500
-2% -$229K
ELV icon
11
Elevance Health
ELV
$81.5B
$9.26M 2.62%
49,215
-6,883
-12% -$1.24M
EVHC
12
DELISTED
Envision Healthcare Holdings Inc
EVHC
$8.96M 2.53%
142,918
+77,018
+117% +$4.44M
SHPG
13
DELISTED
Shire pic
SHPG
$8.76M 2.48%
52,996
-13,100
-20% -$2.29M
SYK icon
14
Stryker
SYK
$125B
$8.64M 2.44%
62,266
+21,203
+52% +$2.91M
BIIB icon
15
Biogen
BIIB
$30B
$8.58M 2.43%
31,632
+20,400
+182% +$5.39M
AET
16
DELISTED
Aetna Inc
AET
$8.57M 2.42%
56,427
-21,400
-27% -$3.02M
NSTG
17
DELISTED
NanoString Technologies, Inc.
NSTG
$8.43M 2.38%
509,660
+421,360
+477% +$7.44M
ESRX
18
DELISTED
Express Scripts Holding Company
ESRX
$8.27M 2.34%
129,490
+11,463
+10% +$720K
AGN
19
DELISTED
Allergan plc
AGN
$8.15M 2.3%
33,527
+6,111
+22% +$1.44M
CAH icon
20
Cardinal Health
CAH
$53.9B
$7.85M 2.22%
100,691
+7,400
+8% +$558K
PFE icon
21
Pfizer
PFE
$143B
$7.77M 2.2%
243,896
+11,489
+5% +$362K
GILD icon
22
Gilead Sciences
GILD
$162B
$7.07M 2%
99,900
+77,900
+354% +$5.18M
IRTC icon
23
iRhythm Holdings
IRTC
$3.85B
$7.03M 1.99%
+165,500
New +$6.03M
CELG
24
DELISTED
Celgene Corp
CELG
$6.65M 1.88%
51,200
-6,300
-11% -$772K
XRAY icon
25
Dentsply Sirona
XRAY
$2.68B
$6.32M 1.79%
+97,400
New +$6.15M
1
2 3 4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Endurant Capital Management held 110 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Endurant Capital Management deployed $21.7M of net new capital in Q2 2017, opening 22 new positions and adding to 38 existing holdings. Its largest new stake was Dentsply Sirona: 97,400 shares worth $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Hologic, an estimated $4.46M trimmed.

  • Endurant Capital Management's largest Q2 2017 buy was Dentsply Sirona: 97,400 shares worth $6.32M.
  • Endurant Capital Management added most to McKesson in Q2 2017, an estimated $9.24M increase.
  • Endurant Capital Management's biggest Q2 2017 reduction was Hologic, cutting an estimated $4.46M.
  • Endurant Capital Management fully exited CATALENT, INC. in Q2 2017, selling an estimated $8.25M.
  • Endurant Capital Management's ten largest holdings make up 34% of its $354M portfolio in Q2 2017.
  • Endurant Capital Management opened 22 new positions and closed 18 in Q2 2017.
  • Endurant Capital Management's portfolio value rose 14% quarter-over-quarter to $354M.

Based on Endurant Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.